Risk factors for Parkinson's disease may differ in men and women: An exploratory study

Hormones and Behavior

Volumn 63, Issue 2, 2013, Pages 308-314

  Savica, Rodolfo ^a,b   Grossardt, Brandon R ^a   Bower, James H ^b   Ahlskog, J Eric ^b   Rocca, Walter A ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Brain dimorphism; Case control study; Gene environment interactions; Parkinson's disease; Risk factors; Sex

Indexed keywords

PESTICIDE;

ADULT; AGED; ANEMIA; CASE CONTROL STUDY; COFFEE; CONTROLLED STUDY; DEMENTIA; EDUCATIONAL STATUS; ESSENTIAL TREMOR; EXPLORATORY RESEARCH; FAMILY HISTORY; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HEAD INJURY; HUMAN; HYSTERECTOMY; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MENTAL DISEASE; PARKINSON DISEASE; PARKINSONISM; PESTICIDE SPRAYING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS; SEX FACTORS;

EID: 84872847516     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2012.05.013     Document Type: Review

References (61)

1. Allen J.S., Damasio H., Grabowski T.J., Bruss J., Zhang W. Sexual dimorphism and asymmetries in the gray-white composition of the human cerebrum. Neuroimage 2003, 18(4):880-894.
2. Arabia G., Grossardt B.R., Geda Y.E., Carlin J.M., Bower J.H., Ahlskog J.E., Maraganore D.M., Rocca W.A. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch. Gen. Psychiatry 2007, 64(12):1385-1392.
3. Baldereschi M., Di Carlo A., Rocca W.A., Vanni P., Maggi S., Perissinotto E., Grigoletto F., Amaducci L., Inzitari D. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000, 55(9):1358-1363.
4. Baron-Cohen S., Knickmeyer R.C., Belmonte M.K. Sex differences in the brain: implications for explaining autism. Science 2005, 310(5749):819-823.
5. Baxter L.C., Saykin A.J., Flashman L.A., Johnson S.C., Guerin S.J., Babcock D.R., Wishart H.A. Sex differences in semantic language processing: a functional MRI study. Brain Lang. 2003, 84(2):264-272.
6. Benedetti M.D., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., Schaid D.J., Rocca W.A. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000, 55(9):1350-1358.
7. Benedetti M.D., Maraganore D.M., Bower J.H., McDonnell S.K., Peterson B.J., Ahlskog J.E., Schaid D.J., Rocca W.A. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov. Disord. 2001, 16(5):830-837.
8. Bower J.H., Maraganore D.M., McDonnell S.K., Rocca W.A. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999, 52(6):1214-1220.
9. Bower J.H., Maraganore D.M., Peterson B.J., McDonnell S.K., Ahlskog J.E., Rocca W.A. Head trauma preceding PD: a case-control study. Neurology 2003, 60(10):1610-1615.
10. Bower J.H., Maraganore D.M., Peterson B.J., Ahlskog J.E., Rocca W.A. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 2006, 67(3):494-496.
11. Braeutigam S., Rose S.P., Swithenby S.J., Ambler T. The distributed neuronal systems supporting choice-making in real-life situations: differences between men and women when choosing groceries detected using magnetoencephalography. Eur. J. Neurosci. 2004, 20(1):293-302.
12. Breiman L., Frideman J., Oslhen R., Stone C. Classification and Regression Trees 1984, CRC Press, Boca Raton, FL.
13. Callier S., Morissette M., Grbois M., Di Paolo T. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Synapse 2000, 37(4):245-251.
14. Datla K.P., Murray H.E., Pillai A.V., Gillies G.E., Dexter D.T. Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. Neuroreport 2003, 14(1):47-50.
15. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5(6):525-535.
16. Dewing P., Chiang C.W., Sinchak K., Sim H., Fernagut P.O., Kelly S., Chesselet M.F., Micevych P.E., Albrecht K.H., Harley V.R., Vilain E. Direct regulation of adult brain function by the male-specific factor SRY. Curr. Biol. 2006, 16(4):415-420.
17. Dluzen D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 1997, 767(2):340-344.
18. Ehrt U., Bronnick K., De Deyn P.P., Emre M., Tekin S., Lane R., Aarsland D. Subthreshold depression in patients with Parkinson's disease and dementia-clinical and demographic correlates. Int. J. Geriatr. Psychiatry 2007, 22(10):980-985.
19. Elbaz A., Moisan F. Update in the epidemiology of Parkinson's disease. Curr. Opin. Neurol. 2008, 21(4):454-460.
20. Elbaz A., Peterson B.J., Yang P., Van Gerpen J.A., Bower J.H., Maraganore D.M., McDonnell S.K., Ahlskog J.E., Rocca W.A. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology 2002, 13(2):157-164.
21. Elbaz A., McDonnell S.K., Maraganore D.M., Strain K.J., Schaid D.J., Bower J.H., Ahlskog J.E., Rocca W.A. Validity of family history data on PD: evidence for a family information bias. Neurology 2003, 61(1):11-17.
22. Frigerio R., Elbaz A., Sanft K.R., Peterson B.J., Bower J.H., Ahlskog J.E., Grossardt B.R., de Andrade M., Maraganore D.M., Rocca W.A. Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology 2005, 65(10):1575-1583.
23. Frigerio R., Sanft K.R., Grossardt B.R., Peterson B.J., Elbaz A., Bower J.H., Ahlskog J.E., de Andrade M., Maraganore D.M., Rocca W.A. Chemical exposures and Parkinson's disease: a population-based case-control study. Mov. Disord. 2006, 21(10):1688-1692.
24. Gajjar T.M., Anderson L.I., Dluzen D.E. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J. Neural Transm. 2003, 110(11):1215-1224.
25. Gao X., Dluzen D.E. Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system. Neuroscience 2001, 103(2):385-394.
26. Gillies G.E., McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol. Rev. 2010, 62(2):155-198.
27. Gillies G.E., Murray H.E., Dexter D., McArthur S. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease. Pharmacol. Biochem. Behav. 2004, 78(3):513-522.
28. Haaxma C.A., Bloem B.R., Borm G.F., Oyen W.J.G., Leenders K.L., Eshuis S., Booij J., Dluzen D.E., Horstink M.W.I.M. Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78(8):819-824.
29. Leranth C., Roth R.H., Elsworth J.D., Naftolin F., Horvath T.L., Redmond D.E. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J. Neurosci. 2000, 20(23):8604-8609.
30. Maraganore D.M., de Andrade M., Lesnick T.G., Farrer M.J., Bower J.H., Hardy J.A., Rocca W.A. Complex interactions in Parkinson's disease: a two-phased approach. Mov. Disord. 2003, 18(6):631-636.
31. Maraganore D.M., Farrer M.J., Lesnick T.G., de Andrade M., Bower J.H., Hernandez D., Hardy J.A., Rocca W.A. Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease. Mov. Disord. 2003, 18(11):1233-1239.
32. Marras C., Goldman S., Smith A., Barney P., Aston D., Comyns K., Korell M., Langston J.W., Ross G.W., Tanner C.M. Smell identification ability in twin pairs discordant for Parkinson's disease. Mov. Disord. 2005, 20(6):687-693.
33. Melton L.J. History of the Rochester Epidemiology Project. Mayo Clin. Proc. 1996, 71(3):266-274.
34. Miller D.B., Ali S.F., O'Callaghan J.P., Laws S.C. The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. N. Y. Acad. Sci. 1998, 844:153-165.
35. Nelson L.M., Bloch D.A., Longstreth W.T., Shi H. Recursive partitioning for the identification of disease risk subgroups: a case-control study of subarachnoid hemorrhage. J. Clin. Epidemiol. 1998, 51(3):199-209.
36. Orr-Urtreger A., Shifrin C., Rozovski U., Rosner S., Bercovich D., Gurevich T., Yagev-More H., Bar-Shira A., Giladi N. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?. Neurology 2007, 69(16):1595-1602.
37. Pakkenberg B., Gundersen H.J. Neocortical neuron number in humans: effect of sex and age. J. Comp. Neurol. 1997, 384(2):312-320.
38. Pankratz N., Nichols W.C., Uniacke S.K., Halter C., Rudolph A., Shults C., Conneally P.M., Foroud T. Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am. J. Hum. Genet. 2002, 71(1):124-135.
39. Rajput A.H., Offord K.P., Beard C.M., Kurland L.T. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann. Neurol. 1984, 16(3):278-282.
40. Rocca W.A., McDonnell S.K., Strain K.J., Bower J.H., Ahlskog J.E., Elbaz A., Schaid D.J., Maraganore D.M. Familial aggregation of Parkinson's disease: The Mayo Clinic Family Study. Ann. Neurol. 2004, 56(4):495-502.
41. Rocca W.A., Peterson B.J., McDonnell S.K., Bower J.H., Ahlskog J.E., Schaid D.J., Maraganore D.M. The Mayo Clinic Family Study of Parkinson's Disease: study design, instruments, and sample characteristics. Neuroepidemiology 2005, 24(3):151-167.
42. Rocca W.A., Bower J.H., Ahlskog J.E., Elbaz A., Grossardt B.R., McDonnell S.K., Schaid D.J., Maraganore D.M. Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch. Neurol. 2007, 64(10):1458-1464.
43. Rocca W.A., Bower J.H., Ahlskog J.E., Elbaz A., Grossardt B.R., McDonnell S.K., Schaid D.J., Maraganore D.M. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov. Disord. 2007, 22(11):1607-1614.
44. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 2008, 70(3):200-209.
45. Ross C.A., Smith W.W. Gene-environment interactions in Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13(Suppl. 3):S309-S315.
46. Saunders-Pullman R., Stanley K., San Luciano M., Barrett M.J., Shanker V., Raymond D., Ozelius L.J., Bressman S.B. Gender differences in the risk of familial parkinsonism: beyond LRRK2?. Neurosci. Lett. 2011, 496(2):125-128.
47. Saunders-Pullman R., Wang C., Stanley K., Bressman S.B. Diagnosis and referral delay in women with Parkinson's disease. Gend. Med. 2011, 8(3):209-217.
48. Savica R., Carlin J.M., Grossardt B.R., Bower J.H., Ahlskog J.E., Maraganore D.M., Bharucha A.E., Rocca W.A. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 2009, 73(21):1752-1758.
49. Savica R., Grossardt B.R., Carlin J.M., Icen M., Bower J.H., Ahlskog J.E., Maraganore D.M., Steensma D.P., Rocca W.A. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology 2009, 73(17):1381-1387.
50. Savica R., Rocca W.A., Ahlskog J.E. When does Parkinson disease start?. Arch. Neurol. 2010, 67(7):798-801.
51. Sawada H., Shimohama S. Estrogens and Parkinson disease: novel approach for neuroprotection. Endocrine 2003, 21(1):77-79.
52. Scott B., Borgman A., Engler H., Johnels B., Aquilonius S.M. Gender differences in Parkinson's disease symptom profile. Acta Neurol. Scand. 2000, 102(1):37-43.
53. Shaywitz B.A., Shaywitz S.E., Pugh K.R., Constable R.T., Skudlarski P., Fulbright R.K., Bronen R.A., Fletcher J.M., Shankweiler D.P., Katz L., Gore J.C. Sex differences in the functional organization of the brain for language. Nature 1995, 373(6515):607-609.
54. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., Schaid D.J., Rocca W.A. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov. Disord. 2000, 15(4):669-677.
55. St Sauver J.L., Grossardt B.R., Yawn B.P., Melton L.J., Rocca W.A. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am. J. Epidemiol. 2011, 173(9):1059-1068.
56. St Sauver J.L., Grossardt B.R., Leibson C.L., Yawn B.P., Melton L.J., Rocca W.A. Generalizability of epidemiologic findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin. Proc. 2012, 87(2):151-160.
57. Szklo M., Nieto F.J. Epidemiology: Beyond the Basics 2007, Jones and Bartlett Publishers, Sudbury. 2nd ed.
58. Tanner C.M., Goldman S.M. Epidemiology of Parkinson's disease. Neurol. Clin. 1996, 14(2):317-335.
59. Van Den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., Nelson L.M. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 2003, 157(11):1015-1022.
60. Wooten G.F., Currie L.J., Bovbjerg V.E., Lee J.K., Patrie J. Are men at greater risk for Parkinson's disease than women?. J. Neurol. Neurosurg. Psychiatry 2004, 75(4):637-639.
61. Zhang H., Bonney G. Use of classification trees for association studies. Genet. Epidemiol. 2000, 19(4):323-332.